Annual Total Expenses
$213.15 M
+$45.45 M+27.11%
December 31, 2024
Summary
- As of March 12, 2025, KROS annual total expenses is $213.15 million, with the most recent change of +$45.45 million (+27.11%) on December 31, 2024.
- During the last 3 years, KROS annual total expenses has risen by +$136.67 million (+178.72%).
- KROS annual total expenses is now at all-time high.
Performance
KROS Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$55.06 M
-$3.99 M-6.75%
December 31, 2024
Summary
- As of March 12, 2025, KROS quarterly total expenses is $55.06 million, with the most recent change of -$3.99 million (-6.75%) on December 31, 2024.
- Over the past year, KROS quarterly total expenses has stayed the same.
- KROS quarterly total expenses is now -6.75% below its all-time high of $59.05 million, reached on September 30, 2024.
Performance
KROS Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
KROS Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.1% | 0.0% |
| 3 y3 years | +178.7% | +121.4% |
| 5 y5 years | +965.5% | +953.1% |
KROS Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +178.7% | -6.8% | +128.2% |
| 5 y | 5-year | at high | +965.5% | -6.8% | +953.1% |
| alltime | all time | at high | +1782.7% | -6.8% | +1053.5% |
Keros Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $213.15 M(+27.1%) | $55.06 M(-6.8%) |
| Sep 2024 | - | $59.05 M(+17.0%) |
| Jun 2024 | - | $50.48 M(+3.9%) |
| Mar 2024 | - | $48.57 M(+9.9%) |
| Dec 2023 | $167.69 M(+55.7%) | $44.20 M(+2.1%) |
| Sep 2023 | - | $43.29 M(+4.7%) |
| Jun 2023 | - | $41.34 M(+6.3%) |
| Mar 2023 | - | $38.87 M(+21.6%) |
| Dec 2022 | $107.71 M(+40.8%) | $31.96 M(+31.7%) |
| Sep 2022 | - | $24.27 M(-11.3%) |
| Jun 2022 | - | $27.35 M(+13.4%) |
| Mar 2022 | - | $24.13 M(-3.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $76.47 M(+73.0%) | $24.87 M(+23.1%) |
| Sep 2021 | - | $20.20 M(+29.1%) |
| Jun 2021 | - | $15.64 M(-0.8%) |
| Mar 2021 | - | $15.77 M(+45.6%) |
| Dec 2020 | $44.20 M(+120.9%) | $10.83 M(-9.3%) |
| Sep 2020 | - | $11.95 M(+9.5%) |
| Jun 2020 | - | $10.91 M(+3.9%) |
| Mar 2020 | - | $10.50 M(+100.9%) |
| Dec 2019 | $20.00 M(+76.7%) | $5.23 M(+8.3%) |
| Sep 2019 | - | $4.83 M(+1.1%) |
| Jun 2019 | - | $4.77 M(-7.8%) |
| Mar 2019 | - | $5.18 M |
| Dec 2018 | $11.32 M | - |
FAQ
- What is Keros Therapeutics annual total expenses?
- What is the all time high annual total expenses for Keros Therapeutics?
- What is Keros Therapeutics annual total expenses year-on-year change?
- What is Keros Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Keros Therapeutics?
- What is Keros Therapeutics quarterly total expenses year-on-year change?
What is Keros Therapeutics annual total expenses?
The current annual total expenses of KROS is $213.15 M
What is the all time high annual total expenses for Keros Therapeutics?
Keros Therapeutics all-time high annual total expenses is $213.15 M
What is Keros Therapeutics annual total expenses year-on-year change?
Over the past year, KROS annual total expenses has changed by +$45.45 M (+27.11%)
What is Keros Therapeutics quarterly total expenses?
The current quarterly total expenses of KROS is $55.06 M
What is the all time high quarterly total expenses for Keros Therapeutics?
Keros Therapeutics all-time high quarterly total expenses is $59.05 M
What is Keros Therapeutics quarterly total expenses year-on-year change?
Over the past year, KROS quarterly total expenses has changed by $0.00 (0.00%)